Back to Search Start Over

Leflunomide: Traditional immunosuppressant with concurrent antiviral effects.

Authors :
Zheng, Kunyu
Chen, Yiran
Liu, Suying
He, Chengmei
Yang, Yunjiao
Wu, Di
Wang, Li
Li, Mengtao
Zeng, Xiaofeng
Zhang, Fengchun
Source :
International Journal of Rheumatic Diseases; Feb2023, Vol. 26 Issue 2, p195-209, 15p
Publication Year :
2023

Abstract

Leflunomide is a classic disease‐modifying anti‐rheumatic drug that is widely used to treat autoimmune diseases. Studies also show its antiviral effects in in vitro and/or in vivo experiments. Considering glucocorticoids, immunosuppressants and newly emerged antibodies commonly used in autoimmune diseases and autoinflammatory disorders bring risk of infection such as viral infection, leflunomide with combination of anti‐viral and immunosuppressive features to maintain the balance between infection and anti‐inflammation are attractive. Here we summarize the actions and mechanisms of leflunomide in immunoregulatory and antiviral effects. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17561841
Volume :
26
Issue :
2
Database :
Complementary Index
Journal :
International Journal of Rheumatic Diseases
Publication Type :
Academic Journal
Accession number :
161547702
Full Text :
https://doi.org/10.1111/1756-185X.14491